REVANCE THERAPEUTICS INC

CUSIP: 761330AB5 Class: NOTE 1.750% 2/1

Boussard & Gavaudan Investment Management LLP's Holding History (CIK: 0001614986)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 12,816 Value ($000) $13,535 Avg Close — Range —
Q1 2023
Shares 5,000 Value ($000) $6,146 Avg Close — Range —